Vascular Graft Infections

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1800 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-05-31

Study Completion Date

2023-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Vascular grafts are increasingly implanted due to an increasing prevalence of atherosclerosis and diabetes, and about 1-6% of vascular procedures are complicated by infection. Mortality attributable to prosthetic vascular graft infections (PVGI) is high. However, there are almost no data regarding best treatment options of such complicated infections. Most recommendations are based on expert opinion and not on clinical trials or cohort observational data analyses. Evaluating infectious and other complications after vascular surgery procedures are important, and additionally, such studies may offer insights for quality improvement and improved patient outcomes. With the first aim investigators will establish an infrastructure for studying PVGI in Zurich. Investigators will take advantage of the Swissvasc registry, a central registry which collects preoperative, operative and discharge data regarding the index vascular surgical interventions. They will create a prospective observational cohort database of all patients who receive a vascular graft (peripheral, aortic, vein) at the University hospital of Zurich (VASGRA Cohort A). Patients with a PVGI will be included in VASGRA Cohort B and followed up using a flow chart with a focus on the course of this infectious complication. Additionally, investigators will establish a biobank with the collection of tissue- and blood samples of patients with PVGI. With the second aim researchers will investigate different diagnostic, clinical and therapeutic research questions nested in the VASGRA Cohort. Firstly, they will address epidemiological questions, such as: determine the incidence and outcome of complications after vascular graft placement; determine risk factors, best treatment strategies and outcome of PVGI, and determine the influence of different antibiotic regimens on the outcome of PVGI due to different bacterial pathogens. Secondly, investigators will determine the accuracy of different imaging techniques (PET/CT and MRI) for the diagnosis of PVGI, and their individual role for the assessment of treatment response. Thirdly, investigators will evaluate the bacterial diversity of vascular wound infections using 16s r-Ribonucleic acid (RNA)amplification, and investigators will explore whether this bacterial diversity does predict disease progression. Here, investigators will also study the impact of negative pressure wound therapy (NPWT) on bacterial diversity in the treatment course of PVGI. Fourthly, investigators will look for cut-off levels of relevant blood leucocytes count, C-reactive protein and procalcitonin raising suspicion of a PVGI. Lastly, investigators will look at histopathological features of excised vascular grafts. Expected value of the project: Results from the proposed study are an important contribution to the field, based on the large sample size, longitudinal design and by unifying clinical and epidemiological science. The very well characterized patient groups and the close connection between vascular surgeons, infectious disease specialists, specialists in nuclear medicine and microbiologist will help to investigate PVGI in depths. Investigators hope to be able to develop guidelines regarding best diagnostic modalities and treatment options in case of vascular graft infections. In the future we plan to examine bacteria retrieved from the PVGI in the laboratory in detail. The recovered bacteria will be examined for antimicrobial susceptibility and their capability to form biofilms. Furthermore investigators will examine how bacterial recovery form explanted grafts could be optimized.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Negative Pressure Wound Therapy for Prevention of Groin Infection Following Vascular Surgery

NCT03460262

Infection Wound

UNKNOWN NA

Non-Healing Ulcers Without Critical Limb Ischemia

NCT01666093

Peripheral Artery Disease Without Critical Limb Ischemia

UNKNOWN PHASE2

Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers

NCT00189540

Arterial Occlusive Disease Peripheral Vascular Disease Ischemia +1 more

COMPLETED PHASE2

Local Application of Combined Optical and Magnetic Stimulation (COMS) for Treatment of Chronic Wounds: Safety Evaluation

NCT03112395

Leg Ulcers Venous Leg Ulcer Arterial Leg Ulcer Mixed

COMPLETED NA

Study to Evaluate the PICO 14 Negative Pressure Wound Therapy System in the Management of Acute and Chronic Wounds

NCT05234632

Surgical Incision Ulcer Foot Ulcer Venous +3 more

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prosthetic Vascular Graft Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prosthetic vascular graft implantation, follow up

Prosthetic vascular graft

Intervention Type DEVICE

Implantation of a prosthetic vascular graft

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prosthetic vascular graft

Implantation of a prosthetic vascular graft

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Valsalva Graft, Gelwave TM Subclavia Graft, Gelwave TM Longer Ante-Flo Offset branch, Gelwave TM Lupiae Branched Graft, Gelwave TM 4 Branched Plexus, Gelwave TM Bifurcate, Gelwave TM soft Subclavia Graft straight, Gelwave TM soft Intergard woven straight, Intervascular "Maquet Getinge Group" Intergard woven hemabridge, Intervascular "Maquet Getinge Group" Intergard woven Aortic Arch, Intervascular "Maquet Getinge Group" Intergard Silver Knitted Bifurcation, Intervascular "Maquet Getinge Group" Intergard Silver Knitted Straight, Intervascular "Maquet Getinge Group" InterGard TM knitted Bifurcation, Intervascular "Maquet Getinge Group" FlowLine Bipore r Heparin ePTFE Vascular Graft, Jotec r GmbH ePTFE Vascular Graft Regular Wall flex, IMPRA r ePTFE Vascular Graft Thin Wall flex, IMPRA r ePTFE Vascular Graft Regular Wall straight, IMPRA r Gore-Tex Stretch Vascular Graft standard Wall Eptfe, W.L. Gore & Associates, Inl

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Control patients:

\- Vascular graft surgery (peripheral, aortic, vein)

Case patients:

* Patients with previous primary implantation of an aortic or peripheral vascular implant and suspicion of PVGI
* Age \>18 years
* Written informed consent

Exclusion Criteria

* Drug or alcohol abuse
* Involvement in a conflicting clinical trial (investigational drug)
* Inability to follow the procedures of the cohort, e.g. due to language problems, psychological disorders or dementia of the subject
* Known or suspected non-compliance

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No